fullerene c60 has been researched along with glucosamine in 1 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (glucosamine) | Trials (glucosamine) | Recent Studies (post-2010) (glucosamine) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 10,273 | 280 | 1,467 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cam, E; Fluri, F; Grünstein, D; Hatz, F; Israel, I; Kleinschnitz, C; Moch, H; Orts-Gil, G; Samnick, S; Schaeren-Wiemers, N; Schäfer, J; Seeberger, P; Ungethuem, U; Zeis, T | 1 |
1 other study(ies) available for fullerene c60 and glucosamine
| Article | Year |
|---|---|
Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats.
Topics: Animals; Brain Ischemia; Cerebral Infarction; Fullerenes; Glucosamine; Hypertension; Injections, Intravenous; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke | 2015 |